Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

August 2015

New HEDIS Measure:  Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) 

The new Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) HEDIS measure calculates the percentage of children ages 1–17 who have had two or more antipsychotic prescriptions filled and at least one metabolic test for blood glucose HbA1c, and at least one test for low-density lipoprotein cholesterol (LCL-C) or total cholesterol each year. Examples of first and second-generation antipsychotic medications included in this measure are chlorpromazine, aripiprazole, clozapine, olanzapine, risperidone, haloperidol, and trifluoperazine.

As you know, while antipsychotic medications are effective in treating certain mental illnesses in children, their side effects can lead to or exacerbate other health problems. Children taking antipsychotics are prone to significant weight gain and obesity-related complications such as cardiovascular issues, hypertension, hypercholesterolemia, and insulin-resistant type 2 diabetes. Consequently, it is important that patients on antipsychotic medication have annual metabolic testing.

In June, Harvard Pilgrim sent registries to pediatricians and prescribers, listing their patients ages 1-17 who had two or more antipsychotic prescriptions filled and were missing a cholesterol and/or blood glucose test in the calendar year. We will be sending these registries out twice a year, with the next mailing occurring in September. For more information about this Harvard Pilgrim initiative, contact the Clinical Programs Department at 800-287-9793 (option 1).

Email this article to a colleague   

Network Matters Archives

Download printer-friendly version


ICD-10 Transition & Paper Claims Submission


New Clinical Medical Policies

Medical Criteria for Inverted Nipple Repair

The Safe Storage and Disposal of Opioids

New HEDIS Measure:  Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM)

Prior Authorization Required for Duexis and Vimovo

Prior Authorization Required for Entresto

ICORE Healthcare Becoming Magellan Rx Pharmacy, LLC

Coordination of Care for Transgender Patients

Harvard Pilgrim’s EatRight Rewards Promotes Wellness


Bilateral Reimbursement

Update Coming to HPHConnect for Providers

Reminder: Save Time and Paper with Harvard Pilgrim’s Electronic Tools


Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Vice President, Network Services

Annmarie Dadoly,

Joseph O'Riordan,

Kristin Edmonston,
Production Coordinator